Related Experiment Video
Updated: Apr 20, 2026
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
21.3K
Adaptive radiation therapy for pediatric head and neck malignancies: Dosimetric implications
Siddhartha Laskar1, Prakash Pandit1, Suman Mallik1
1Department of Radiation Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Practical Radiation Oncology
|November 22, 2014
Summary
Adaptive radiation therapy significantly reduces spinal cord dose and improves treatment plan quality in pediatric head and neck cancer patients. This approach enhances radiation delivery for improved outcomes.
Area of Science:
- Pediatric Oncology
- Radiation Oncology
- Medical Imaging
Background:
- Anatomical changes during radiation therapy can compromise treatment accuracy.
- Conformal radiation therapy for pediatric head and neck cancers requires precise targeting.
- Adaptive radiation therapy (ART) aims to adjust treatment based on real-time anatomical changes.
Purpose of the Study:
- To evaluate the role and effectiveness of adaptive radiation therapy (ART) in pediatric patients undergoing curative radiation therapy for head and neck cancers.
- To assess dosimetric differences between original, non-optimized, and re-optimized radiation therapy plans.
Main Methods:
- Ten pediatric patients with head and neck cancers received conformal radiation therapy.
- Anatomical changes were assessed mid-treatment using imaging.
- Treatment plans were re-optimized based on updated contours, and dosimetric parameters were compared.
Main Results:
- Significant average reduction in gross tumor volume (40%) was observed.
- Non-optimized plans led to a 15% average increase in spinal cord maximum dose.
- Re-optimization reduced spinal cord maximum dose by 9.73% and decreased integral dose by 5%.
Conclusions:
- Adaptive radiation therapy is a valuable tool for optimizing radiation delivery in pediatric head and neck cancer.
- ART improves target coverage and reduces dose to organs at risk, enhancing treatment efficacy and safety.
More Related Videos
Related Concept Videos
01:29Drug Dosing: Infants and Children
944
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
944
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
393
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
393
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
518
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
518